From lab to bedside: ensuring new medicines are available in a cost-effective and timely way

From lab to bedside: ensuring new medicines are available in a cost-effective and timely way At a challenging time for the NHS in terms of finances, demand for services and patient expectations, policy-makers need to ensure patients have access to new medicines in a cost-effective and timely way. Many of these new medicines are predicted to add high costs to a rising medicines bill, meaning the NHS will find it increasingly difficult to offer new medicines within current financial constraints. NHS England and National Institute for Health and Care Excellence (NICE) are trying to answer this challenge, but doing so without restricting patient access is proving difficult. The King's Fund